Streamlining variations: UK scheme allows drug firms to update all product information in one go
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare Products Regulatory Agency is inviting drug companies to test more widely a new scheme on co-ordinated submission and assessment of variations and changes to the packaging/patient information leaflet that are submitted in parallel to amend a marketing authorization application1,2.